Literature DB >> 12180202

Insertion of percutaneous endoscopic gastrostomy tubes by a maxillofacial surgical team in patients with oropharyngeal cancer.

C J Lloyd1, C N Penfold.   

Abstract

This study assessed the clinical outcome after insertion of a percutaneous endoscopic gastrostomy tube (PEGT) by a maxillofacial team in a series of 54 patients. The indication for PEG feeding was any patient with oropharyngeal cancer who was unlikely to return to oral feeding within 14 days. Fifty-two patients (96%) had tubes successfully inserted at the time of examination under anaesthesia (n = 19) or definitive operation (n = 33). Feeding was established at a median of 2 days (range 1-6). Median duration of tube feeding was 18 weeks (range 4-70). There were no deaths or major complications and 10 minor complications. No tube was lost or required premature removal. We conclude that insertion of a PEG tube is a procedure that can be done safely by maxillofacial surgeons.

Entities:  

Mesh:

Year:  2002        PMID: 12180202     DOI: 10.1054/bjom.2001.0683

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  3 in total

1.  Prospective experience of percutaneous endoscopic gastrostomy tubes placed by otorhinolaryngologist-head and neck surgeons: safe and efficacious.

Authors:  Johanna Ruohoalho; Katri Aro; Antti A Mäkitie; Timo Atula; Aaro Haapaniemi; Harri Keski-Säntti; Leena Kylänpää; Annika Takala; Leif J Bäck
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-01       Impact factor: 2.503

Review 2.  Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy.

Authors:  Brenda Nugent; Sian Lewis; Joe M O'Sullivan
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

3.  Percutaneous endoscopic gastrostomy (PEG) - An useful 'surgical' measure.

Authors:  Saumitra Saha; Anandabrata Bose
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2006-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.